Yamada S - Search Results

1

Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer.

Kanda M, Shimizu D, Sawaki K, Nakamura S, Umeda S, Miwa T, Tanaka H, Tanaka C, Hayashi M, Iguchi Y, Yamada S, Katsuno M, Kodera Y. Kanda M, et al. Among authors: yamada s. Mol Cancer. 2020 Aug 26;19(1):131. doi: 10.1186/s12943-020-01251-0. Mol Cancer. 2020. PMID: 32847597 Free PMC article.

2

Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.

Yamada S, Takeda S, Fujii T, Nomoto S, Kanazumi N, Sugimoto H, Kasuya H, Kodera Y, Nagasaka T, Morita S, Nakao A. Yamada S, et al. Ann Surg. 2007 Aug;246(2):254-8. doi: 10.1097/01.sla.0000261596.43439.92. Ann Surg. 2007. PMID: 17667504 Free PMC article.

3

Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery?

Yamada S, Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Takeda S. Yamada S, et al. Pancreas. 2009 Jan;38(1):e13-7. doi: 10.1097/MPA.0b013e3181889e2d. Pancreas. 2009. PMID: 18797422

4

Pancreatic cancer with distant metastases: a contraindication for radical surgery?

Yamada S, Fujii T, Sugimoto H, Kanazumi N, Kasuya H, Nomoto S, Takeda S, Kodera Y, Nakao A. Yamada S, et al. Hepatogastroenterology. 2009 May-Jun;56(91-92):881-5. Hepatogastroenterology. 2009. PMID: 19621722

5

Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.

Kato K, Yamada S, Sugimoto H, Kanazumi N, Nomoto S, Takeda S, Kodera Y, Morita S, Nakao A. Kato K, et al. Among authors: yamada s. Pancreas. 2009 Aug;38(6):605-12. doi: 10.1097/MPA.0b013e3181a4891d. Pancreas. 2009. PMID: 19629002

6

Middle pancreatectomy: safety and long-term results.

Shikano T, Nakao A, Kodera Y, Yamada S, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Takeda S. Shikano T, et al. Among authors: yamada s. Surgery. 2010 Jan;147(1):21-9. doi: 10.1016/j.surg.2009.04.036. Epub 2009 Aug 14. Surgery. 2010. PMID: 19682717

7

Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas.

Kanda M, Fujii T, Sahin TT, Kanzaki A, Nagai S, Yamada S, Sugimoto H, Nomoto S, Takeda S, Kodera Y, Morita S, Nakao A. Kanda M, et al. Among authors: yamada s. Ann Surg. 2010 Mar;251(3):483-7. doi: 10.1097/SLA.0b013e3181cf9171. Ann Surg. 2010. PMID: 20101172

8

Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas.

Fujii T, Kato K, Kodera Y, Kanda M, Nagai S, Yamada S, Kanzaki A, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakamura S, Nakao A. Fujii T, et al. Among authors: yamada s. Surgery. 2010 Aug;148(2):285-90. doi: 10.1016/j.surg.2010.03.013. Surgery. 2010. PMID: 20434746

9

Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas.

Nagai S, Fujii T, Kodera Y, Kanda M, Sahin TT, Kanzaki A, Yamada S, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakao A. Nagai S, et al. Among authors: yamada s. Pancreas. 2011 Jan;40(1):3-9. doi: 10.1097/MPA.0b013e3181f7147a. Pancreas. 2011. PMID: 20881897

10

A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer.

Nakao A, Kasuya H, Sahin TT, Nomura N, Kanzaki A, Misawa M, Shirota T, Yamada S, Fujii T, Sugimoto H, Shikano T, Nomoto S, Takeda S, Kodera Y, Nishiyama Y. Nakao A, et al. Among authors: yamada s. Cancer Gene Ther. 2011 Mar;18(3):167-75. doi: 10.1038/cgt.2010.65. Epub 2010 Nov 19. Cancer Gene Ther. 2011. PMID: 21102422 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,276 results

Search Page